Skip to content

Neurological MRI-based biomarkers for treatment navigation in depression

Neurological MRI-based biomarkers for treatment navigation in depression - Neurotrend

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55072
Enrollment
180
Registered
2020-09-28
Start date
2021-07-06
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder mood disturbance

Interventions

None listed

Sponsors

Technische Universiteit Eindhoven
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Satisfy DSM-5 clinical criteria for MDD (Only acute and subacute duration (0-2 years), for MDD group only) • Unipolar depression (i.e. no bipolar disorder/mania, for MDD group only) • Age: 18-65 (m/f) • Willing and able to provide informed consent and agree that incidental findings are reported

Exclusion criteria

Exclusion criteria: • Concurrent neurological disorders (e.g. epilepsy, stroke, head trauma, etc.) • Current substance or alcohol abuse • History of psychosis, bipolar depression, autism spectrum disorder, attention deficit hyperactivity disorder or (mild) intellectual disability • Contra-indication for MRI: implants, tattoos non-compatible with brain MRI, pregnancy, claustrophobia • Current or previous treatment with electroconvulsive therapy (ECT), deep-brain stimulation (DBS) or transcranial magnetic stimulation (TMS) • More than 3 depressive episodes in the past (for MDD group only) • Has a current episode of MDD or ever had an MDD episode (for healthy control group only)

Design outcomes

Primary

MeasureTime frame
- Hamilton Depression Rating Scale (HDRS) scores - Treatment / medication usage - MRI metrics (varies per MRI modality, an example is volume per region for a T1-weighted scan and fractional anisotropy for diffusion-weighted scans).

Secondary

MeasureTime frame
- Scores of psychometric assessments (e.g. STAI-DY1 - anxiety score) - Scores of cognitive assessments (e.g. average response time for the eye-tracking task)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)